IDRA Annual SG&A
$9.98 M
-$1.94 M-16.27%
31 December 2021
Summary:
As of January 24, 2025, IDRA annual selling, general & administrative expenses is $9.98 million, with the most recent change of -$1.94 million (-16.27%) on December 31, 2021. During the last 3 years, it has fallen by -$5.44 million (-35.30%).IDRA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDRA Quarterly SG&A
$2.27 M
-$391.00 K-14.70%
30 September 2022
Summary:
As of January 24, 2025, IDRA quarterly selling, general & administrative expenses is $2.27 million, with the most recent change of -$391.00 thousand (-14.70%) on September 30, 2022. Over the past year, it has dropped by -$63.00 thousand (-2.70%).IDRA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDRA TTM SG&A
-$2.97 B
-$16.70 M-0.57%
30 September 2022
Summary:
As of January 24, 2025, IDRA TTM selling, general & administrative expenses is -$2.97 billion, with the most recent change of -$16.70 million (-0.57%) on September 30, 2022. Over the past year, it has dropped by -$2.98 billion (-27375.23%).IDRA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDRA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.3% | -2.7% | -10000.0% |
| 3 y3 years | -35.3% | -25.0% | -10000.0% |
| 5 y5 years | -36.0% | -42.1% | -10000.0% |
IDRA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -36.0% | -44.4% | <-9999.0% |
Idera Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $2.27 M(-14.7%) | $9.34 M(-0.7%) |
| June 2022 | - | $2.66 M(+10.9%) | $9.40 M(+2.0%) |
| Mar 2022 | - | $2.40 M(+18.9%) | $9.22 M(-7.6%) |
| Dec 2021 | $9.98 M(-16.3%) | $2.02 M(-13.5%) | $9.98 M(-8.3%) |
| Sept 2021 | - | $2.33 M(-5.7%) | $10.88 M(-3.4%) |
| June 2021 | - | $2.47 M(-21.7%) | $11.27 M(-1.4%) |
| Mar 2021 | - | $3.16 M(+8.0%) | $11.43 M(-4.1%) |
| Dec 2020 | $11.91 M(-4.5%) | $2.92 M(+7.5%) | $11.91 M(-4.0%) |
| Sept 2020 | - | $2.72 M(+3.3%) | $12.41 M(-2.4%) |
| June 2020 | - | $2.63 M(-27.7%) | $12.72 M(-2.0%) |
| Mar 2020 | - | $3.64 M(+6.5%) | $12.98 M(+4.0%) |
| Dec 2019 | $12.48 M(-19.1%) | $3.42 M(+13.1%) | $12.48 M(-1.2%) |
| Sept 2019 | - | $3.02 M(+4.4%) | $12.63 M(-7.1%) |
| June 2019 | - | $2.90 M(-7.9%) | $13.59 M(-7.5%) |
| Mar 2019 | - | $3.14 M(-12.0%) | $14.70 M(-2.2%) |
| Dec 2018 | $15.42 M(-1.1%) | $3.57 M(-10.4%) | $15.04 M(-0.9%) |
| Sept 2018 | - | $3.98 M(-0.4%) | $15.16 M(+0.4%) |
| June 2018 | - | $4.00 M(+14.9%) | $15.10 M(+0.7%) |
| Mar 2018 | - | $3.48 M(-5.9%) | $14.99 M(-3.8%) |
| Dec 2017 | $15.59 M(+3.0%) | $3.70 M(-5.6%) | $15.59 M(+1.1%) |
| Sept 2017 | - | $3.92 M(+0.8%) | $15.42 M(+0.1%) |
| June 2017 | - | $3.89 M(-4.7%) | $15.41 M(+0.7%) |
| Mar 2017 | - | $4.08 M(+15.6%) | $15.30 M(+1.1%) |
| Dec 2016 | $15.13 M(-1.7%) | $3.53 M(-9.6%) | $15.13 M(-1.2%) |
| Sept 2016 | - | $3.91 M(+3.4%) | $15.31 M(-0.8%) |
| June 2016 | - | $3.78 M(-3.5%) | $15.43 M(-0.3%) |
| Mar 2016 | - | $3.92 M(+5.6%) | $15.47 M(+0.5%) |
| Dec 2015 | $15.40 M(+35.9%) | $3.71 M(-8.0%) | $15.40 M(+0.1%) |
| Sept 2015 | - | $4.03 M(+5.5%) | $15.37 M(+8.1%) |
| June 2015 | - | $3.82 M(-0.4%) | $14.22 M(+8.3%) |
| Mar 2015 | - | $3.84 M(+4.1%) | $13.13 M(+15.8%) |
| Dec 2014 | $11.33 M(+46.4%) | $3.69 M(+28.3%) | $11.33 M(+12.4%) |
| Sept 2014 | - | $2.87 M(+5.2%) | $10.08 M(+7.4%) |
| June 2014 | - | $2.73 M(+33.6%) | $9.39 M(+13.7%) |
| Mar 2014 | - | $2.04 M(-16.1%) | $8.26 M(+6.7%) |
| Dec 2013 | $7.74 M(+23.3%) | $2.44 M(+11.8%) | $7.74 M(+17.8%) |
| Sept 2013 | - | $2.18 M(+36.3%) | $6.57 M(+12.0%) |
| June 2013 | - | $1.60 M(+4.7%) | $5.87 M(-4.1%) |
| Mar 2013 | - | $1.53 M(+20.7%) | $6.12 M(-2.6%) |
| Dec 2012 | $6.28 M(-20.9%) | $1.26 M(-14.4%) | $6.28 M(-4.2%) |
| Sept 2012 | - | $1.48 M(-20.1%) | $6.55 M(-6.7%) |
| June 2012 | - | $1.85 M(+9.4%) | $7.02 M(-4.3%) |
| Mar 2012 | - | $1.69 M(+9.7%) | $7.34 M(-7.5%) |
| Dec 2011 | $7.94 M(-19.5%) | $1.54 M(-21.0%) | $7.94 M(-7.2%) |
| Sept 2011 | - | $1.95 M(-10.1%) | $8.56 M(-2.8%) |
| June 2011 | - | $2.17 M(-5.2%) | $8.80 M(-6.6%) |
| Mar 2011 | - | $2.29 M(+5.9%) | $9.42 M(-4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $9.87 M(+15.3%) | $2.16 M(-1.6%) | $9.87 M(+0.9%) |
| Sept 2010 | - | $2.19 M(-21.2%) | $9.78 M(-0.2%) |
| June 2010 | - | $2.78 M(+1.9%) | $9.79 M(+7.1%) |
| Mar 2010 | - | $2.73 M(+32.0%) | $9.14 M(+6.8%) |
| Dec 2009 | $8.56 M(-12.6%) | $2.07 M(-6.4%) | $8.56 M(+2.7%) |
| Sept 2009 | - | $2.21 M(+3.6%) | $8.34 M(-1.1%) |
| June 2009 | - | $2.13 M(-0.7%) | $8.43 M(-11.5%) |
| Mar 2009 | - | $2.15 M(+16.4%) | $9.53 M(-2.7%) |
| Dec 2008 | $9.80 M(+3.0%) | $1.85 M(-19.9%) | $9.80 M(-11.7%) |
| Sept 2008 | - | $2.30 M(-28.7%) | $11.10 M(+2.5%) |
| June 2008 | - | $3.23 M(+33.8%) | $10.82 M(+8.5%) |
| Mar 2008 | - | $2.42 M(-23.2%) | $9.98 M(+4.9%) |
| Dec 2007 | $9.51 M(+51.6%) | $3.14 M(+54.6%) | $9.51 M(+9.7%) |
| Sept 2007 | - | $2.03 M(-14.7%) | $8.67 M(+7.9%) |
| June 2007 | - | $2.38 M(+22.0%) | $8.03 M(+20.9%) |
| Mar 2007 | - | $1.95 M(-15.1%) | $6.65 M(+11.5%) |
| Dec 2006 | $6.28 M(+74.2%) | $2.30 M(+64.9%) | $5.96 M(+31.6%) |
| Sept 2006 | - | $1.40 M(+40.0%) | $4.53 M(+11.9%) |
| June 2006 | - | $997.00 K(-21.4%) | $4.05 M(+1.0%) |
| Mar 2006 | - | $1.27 M(+46.0%) | $4.01 M(+13.2%) |
| Dec 2005 | $3.60 M(+1.2%) | $868.50 K(-5.0%) | $3.54 M(+5.6%) |
| Sept 2005 | - | $913.90 K(-4.6%) | $3.35 M(-15.6%) |
| June 2005 | - | $957.90 K(+19.5%) | $3.97 M(+5.0%) |
| Mar 2005 | - | $801.90 K(+17.9%) | $3.78 M(+6.2%) |
| Dec 2004 | $3.56 M(-52.3%) | $679.90 K(-55.6%) | $3.56 M(-16.4%) |
| Sept 2004 | - | $1.53 M(+99.5%) | $4.26 M(+2.0%) |
| June 2004 | - | $768.20 K(+32.6%) | $4.17 M(-13.3%) |
| Mar 2004 | - | $579.50 K(-57.9%) | $4.82 M(-35.5%) |
| Dec 2003 | $7.47 M(+29.7%) | $1.38 M(-4.9%) | $7.47 M(+3.8%) |
| Sept 2003 | - | $1.45 M(+2.7%) | $7.19 M(-16.9%) |
| June 2003 | - | $1.41 M(-56.3%) | $8.66 M(+7.6%) |
| Mar 2003 | - | $3.23 M(+192.6%) | $8.05 M(+41.3%) |
| Dec 2002 | $5.76 M(-15.5%) | $1.10 M(-62.1%) | $5.70 M(-12.8%) |
| Sept 2002 | - | $2.91 M(+263.0%) | $6.54 M(+43.0%) |
| June 2002 | - | $802.50 K(-8.6%) | $4.57 M(-28.0%) |
| Mar 2002 | - | $878.40 K(-54.8%) | $6.34 M(-6.9%) |
| Dec 2001 | $6.81 M(+114.0%) | $1.94 M(+105.3%) | $6.81 M(+19.2%) |
| Sept 2001 | - | $946.40 K(-63.3%) | $5.71 M(+7.2%) |
| June 2001 | - | $2.58 M(+91.4%) | $5.33 M(+46.9%) |
| Mar 2001 | - | $1.35 M(+59.5%) | $3.63 M(+13.9%) |
| Dec 2000 | $3.18 M(-13.1%) | $844.10 K(+50.2%) | $3.18 M(+36.1%) |
| Sept 2000 | - | $562.00 K(-35.7%) | $2.34 M(+31.6%) |
| June 2000 | - | $874.70 K(-3.2%) | $1.78 M(+96.8%) |
| Mar 2000 | - | $903.20 K | $903.20 K |
| Dec 1999 | $3.66 M(-44.3%) | - | - |
| Dec 1998 | $6.57 M(-40.4%) | - | - |
| Dec 1997 | $11.03 M(-2.8%) | - | - |
| Dec 1996 | $11.35 M | - | - |
FAQ
- What is Idera Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual SG&A year-on-year change?
- What is Idera Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly SG&A year-on-year change?
- What is Idera Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals TTM SG&A year-on-year change?
What is Idera Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of IDRA is $9.98 M
What is the all time high annual SG&A for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual selling, general & administrative expenses is $15.59 M
What is Idera Pharmaceuticals annual SG&A year-on-year change?
Over the past year, IDRA annual selling, general & administrative expenses has changed by -$1.94 M (-16.27%)
What is Idera Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of IDRA is $2.27 M
What is the all time high quarterly SG&A for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $4.08 M
What is Idera Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, IDRA quarterly selling, general & administrative expenses has changed by -$63.00 K (-2.70%)
What is Idera Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of IDRA is -$2.97 B
What is the all time high TTM SG&A for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high TTM selling, general & administrative expenses is $15.59 M
What is Idera Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, IDRA TTM selling, general & administrative expenses has changed by -$2.98 B (-27375.23%)